期刊
JOURNAL OF HUNTINGTONS DISEASE
卷 11, 期 4, 页码 351-367出版社
IOS PRESS
DOI: 10.3233/JHD-229006
关键词
Huntington disease; clinical trials
资金
- Vaccinex Inc.
This article provides an in-depth overview of the PIVOT HD and SIGNAL trials in Huntington's disease, along with a comprehensive list of all currently registered and ongoing clinical trials. It also includes a "breaking news" section highlighting recent updates on the SELECT HD, uniQure AMT-130, and VIBRANT HD clinical trials.
In this edition of the Huntington's Disease Clinical Trials Corner, we expand on the PIVOT HD (PTC518), and SIGNAL (pepinemab) trials, and list all currently registered and ongoing clinical trials in Huntington's disease. We also introduce a `breaking news' section highlighting recent updates about the SELECT HD, uniQure AMT-130, and VIBRANT HD clinical trials.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据